Soluble guanylate cyclase as a therapeutic target in heart failure: modulation of oxidative stress and cardiac remodeling pathways with potential implications for heart failure therapy

12 May 2026 (09:30 - 10:30)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - experimental heart failure (3) Experimental Heart Failure Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by